| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
13,367 |
8,481 |
$979K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
5,872 |
3,929 |
$309K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
1,511 |
1,176 |
$166K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
1,164 |
946 |
$87K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
2,389 |
1,810 |
$60K |
| 99195 |
|
2,728 |
2,098 |
$46K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
319 |
248 |
$25K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
2,406 |
1,453 |
$21K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
165 |
136 |
$14K |
| 99406 |
|
1,211 |
819 |
$11K |
| 99215 |
Prolong outpt/office vis |
156 |
75 |
$9K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
235 |
144 |
$9K |
| 94760 |
|
6,528 |
4,763 |
$8K |
| 99173 |
|
1,484 |
1,117 |
$7K |
| 81000 |
|
1,612 |
1,240 |
$3K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
55 |
51 |
$2K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
89 |
51 |
$2K |
| 90656 |
|
137 |
101 |
$2K |
| 90686 |
|
115 |
78 |
$1K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
141 |
122 |
$1K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
101 |
84 |
$675.54 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
108 |
83 |
$567.38 |
| 94664 |
|
82 |
64 |
$455.40 |
| 99407 |
|
17 |
13 |
$310.18 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
628 |
437 |
$260.10 |
| 93000 |
|
18 |
12 |
$147.68 |
| 80305 |
|
26 |
12 |
$122.40 |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
80 |
57 |
$95.26 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
118 |
65 |
$47.30 |
| J3490 |
Unclassified drugs |
123 |
47 |
$35.75 |
| 85014 |
|
20 |
16 |
$32.48 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
85 |
70 |
$8.73 |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
46 |
25 |
$3.99 |
| 99072 |
|
1,328 |
949 |
$0.00 |
| 99000 |
|
50 |
32 |
$0.00 |